Decreased Release of Gonadotropin-Releasing Hormone During the Preovulatory Midcycle Luteinizing Hormone Surge in Normal Women

To investigate the contribution of hypothalamic gonadotropin-releasing hormone (GnRH) secretion to the midcycle gonadotropin surge in the human, the response of luteinizing hormone (LH) to competitive GnRH receptor blockade achieved by administration of a range of doses of a pure GnRH antagonist was...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Proceedings of the National Academy of Sciences - PNAS 1994-07, Vol.91 (15), p.6894-6898
Hauptverfasser: Hall, Janet E., Taylor, Ann E., Martin, Kathryn A., Rivier, Jean, Schoenfeld, David A., Crowley, William F.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 6898
container_issue 15
container_start_page 6894
container_title Proceedings of the National Academy of Sciences - PNAS
container_volume 91
creator Hall, Janet E.
Taylor, Ann E.
Martin, Kathryn A.
Rivier, Jean
Schoenfeld, David A.
Crowley, William F.
description To investigate the contribution of hypothalamic gonadotropin-releasing hormone (GnRH) secretion to the midcycle gonadotropin surge in the human, the response of luteinizing hormone (LH) to competitive GnRH receptor blockade achieved by administration of a range of doses of a pure GnRH antagonist was used to provide a semiquantitative estimate of endogenous GnRH secretion. The LH response to 5, 15, 50, and 150 μ g/kg s.c. of the NAL-GLU GnRH antagonist ([Ac-D-2Nal1,D-4ClPhe2,D-Pal3,Arg5, D-4-p-methoxybenzoyl-2-aminobutyric acid6,D-Ala10]GnRH, where 2Nal is 2-naphthylalanine, 4ClPhe is 4-chlorophenylalanine, and 3Pal is 3-pyridylalanine) was measured in normal women in the early and late follicular phases of the menstrual cycle, at the time of the midcycle LH surge and in the early luteal phase. LH decreased in a dose-response fashion after administration of the GnRH antagonist in all cycle phases (P < 0.0001). When this suppression was expressed as maximum percent inhibition, there was no difference in response during the early and late follicular and early luteal phases. However, at the midcycle surge, there was a leftward shift of the dose-response curve with significantly greater suppression of LH at the lower antagonist doses in comparison to the other cycle phases (P < 0.005), but no difference at the highest dose. Thus, we draw the following conclusions. (i) There is a consistently greater degree of LH inhibition by GnRH antagonism at the midcycle surge at submaximal degrees of GnRH receptor blockade than at other phases of the menstrual cycle in normal women. (ii) This leftward shift of the dose-response relationship to GnRH receptor blockade suggests that the overall amount of GnRH secreted at the midcycle surge is less than at other cycle stages. (iii) These data confirm the importance of pituitary augmentation of the GnRH signal at the time of the midcycle gonadotropin surge in the human.
doi_str_mv 10.1073/pnas.91.15.6894
format Article
fullrecord <record><control><sourceid>jstor_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_76623584</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>2365185</jstor_id><sourcerecordid>2365185</sourcerecordid><originalsourceid>FETCH-LOGICAL-c555t-29b64ac5ba7d72519b5371daea6cba8470774a304cb978cdc48538520eb7dfa03</originalsourceid><addsrcrecordid>eNp9kc1v1DAQxS0EKtvCmQsgiwOcsrUdO04kLqiFFmn5EB_iaDnO7NYrx17spOpy4G_H0S5L4cDJ9rzfG834IfSIkjklsjzdeJ3mDZ1TMa_qht9BM0oaWlS8IXfRjBAmi5ozfh8dp7QmhDSiJkfoqCacSlrN0M9zMBF0gg5_AjddcFjii-B1F4YYNtYXu7r1K3wZYh884PMxTs_hCvDHCOF6dHoIcYvf2c5sjQO8GAew3v64bfo8xhVg6_H7XNAOfws9-Afo3lK7BA_35wn6-ub1l7PLYvHh4u3Zq0VhhBBDwZq24tqIVstOMkGbVpSSdhp0ZVpdc0mk5Lok3LSNrE1neC3KWjACreyWmpQn6OWu72Zse-gM-CFqpzbR9jpuVdBW_a14e6VW4Vpxnrtm-_O9PYbvI6RB9TYZcE57CGNSsqpYKeoJfPYPuA5j9Hk1xQgtGZGcZeh0B5kYUoqwPMxBiZpSVVOqqqGKCjWlmh1Pbo9_4PcxZv3FXp-Mv9U_DdRydG6AmyGTT_9LZuDxDlinnOmBYGUlaP7UX2_9wok</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>201320742</pqid></control><display><type>article</type><title>Decreased Release of Gonadotropin-Releasing Hormone During the Preovulatory Midcycle Luteinizing Hormone Surge in Normal Women</title><source>MEDLINE</source><source>PMC (PubMed Central)</source><source>Alma/SFX Local Collection</source><source>Free Full-Text Journals in Chemistry</source><source>JSTOR</source><creator>Hall, Janet E. ; Taylor, Ann E. ; Martin, Kathryn A. ; Rivier, Jean ; Schoenfeld, David A. ; Crowley, William F.</creator><creatorcontrib>Hall, Janet E. ; Taylor, Ann E. ; Martin, Kathryn A. ; Rivier, Jean ; Schoenfeld, David A. ; Crowley, William F.</creatorcontrib><description>To investigate the contribution of hypothalamic gonadotropin-releasing hormone (GnRH) secretion to the midcycle gonadotropin surge in the human, the response of luteinizing hormone (LH) to competitive GnRH receptor blockade achieved by administration of a range of doses of a pure GnRH antagonist was used to provide a semiquantitative estimate of endogenous GnRH secretion. The LH response to 5, 15, 50, and 150 μ g/kg s.c. of the NAL-GLU GnRH antagonist ([Ac-D-2Nal1,D-4ClPhe2,D-Pal3,Arg5, D-4-p-methoxybenzoyl-2-aminobutyric acid6,D-Ala10]GnRH, where 2Nal is 2-naphthylalanine, 4ClPhe is 4-chlorophenylalanine, and 3Pal is 3-pyridylalanine) was measured in normal women in the early and late follicular phases of the menstrual cycle, at the time of the midcycle LH surge and in the early luteal phase. LH decreased in a dose-response fashion after administration of the GnRH antagonist in all cycle phases (P &lt; 0.0001). When this suppression was expressed as maximum percent inhibition, there was no difference in response during the early and late follicular and early luteal phases. However, at the midcycle surge, there was a leftward shift of the dose-response curve with significantly greater suppression of LH at the lower antagonist doses in comparison to the other cycle phases (P &lt; 0.005), but no difference at the highest dose. Thus, we draw the following conclusions. (i) There is a consistently greater degree of LH inhibition by GnRH antagonism at the midcycle surge at submaximal degrees of GnRH receptor blockade than at other phases of the menstrual cycle in normal women. (ii) This leftward shift of the dose-response relationship to GnRH receptor blockade suggests that the overall amount of GnRH secreted at the midcycle surge is less than at other cycle stages. (iii) These data confirm the importance of pituitary augmentation of the GnRH signal at the time of the midcycle gonadotropin surge in the human.</description><identifier>ISSN: 0027-8424</identifier><identifier>EISSN: 1091-6490</identifier><identifier>DOI: 10.1073/pnas.91.15.6894</identifier><identifier>PMID: 8041716</identifier><language>eng</language><publisher>United States: National Academy of Sciences of the United States of America</publisher><subject>Adolescent ; Adult ; Amino Acid Sequence ; Anatomy &amp; physiology ; Dosage ; Dose response relationship ; Endocrinology ; Female ; Follicle Stimulating Hormone - blood ; Follicular phase ; Follicular Phase - blood ; Gonadotropin-Releasing Hormone - analogs &amp; derivatives ; Gonadotropin-Releasing Hormone - antagonists &amp; inhibitors ; Gonadotropin-Releasing Hormone - blood ; Hormones ; Humans ; LHRH receptors ; Luteal phase ; Luteinizing Hormone - blood ; Menstruation ; Molecular Sequence Data ; Pretreatment ; Receptors ; Receptors, LHRH - antagonists &amp; inhibitors ; Receptors, LHRH - metabolism ; Reference Values ; Secretion ; Sex hormones ; Women</subject><ispartof>Proceedings of the National Academy of Sciences - PNAS, 1994-07, Vol.91 (15), p.6894-6898</ispartof><rights>Copyright 1994 The National Academy of Sciences of the United States of America</rights><rights>Copyright National Academy of Sciences Jul 19, 1994</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c555t-29b64ac5ba7d72519b5371daea6cba8470774a304cb978cdc48538520eb7dfa03</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Uhttp://www.pnas.org/content/91/15.cover.gif</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/2365185$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/2365185$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>230,314,723,776,780,799,881,27901,27902,53766,53768,57992,58225</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8041716$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hall, Janet E.</creatorcontrib><creatorcontrib>Taylor, Ann E.</creatorcontrib><creatorcontrib>Martin, Kathryn A.</creatorcontrib><creatorcontrib>Rivier, Jean</creatorcontrib><creatorcontrib>Schoenfeld, David A.</creatorcontrib><creatorcontrib>Crowley, William F.</creatorcontrib><title>Decreased Release of Gonadotropin-Releasing Hormone During the Preovulatory Midcycle Luteinizing Hormone Surge in Normal Women</title><title>Proceedings of the National Academy of Sciences - PNAS</title><addtitle>Proc Natl Acad Sci U S A</addtitle><description>To investigate the contribution of hypothalamic gonadotropin-releasing hormone (GnRH) secretion to the midcycle gonadotropin surge in the human, the response of luteinizing hormone (LH) to competitive GnRH receptor blockade achieved by administration of a range of doses of a pure GnRH antagonist was used to provide a semiquantitative estimate of endogenous GnRH secretion. The LH response to 5, 15, 50, and 150 μ g/kg s.c. of the NAL-GLU GnRH antagonist ([Ac-D-2Nal1,D-4ClPhe2,D-Pal3,Arg5, D-4-p-methoxybenzoyl-2-aminobutyric acid6,D-Ala10]GnRH, where 2Nal is 2-naphthylalanine, 4ClPhe is 4-chlorophenylalanine, and 3Pal is 3-pyridylalanine) was measured in normal women in the early and late follicular phases of the menstrual cycle, at the time of the midcycle LH surge and in the early luteal phase. LH decreased in a dose-response fashion after administration of the GnRH antagonist in all cycle phases (P &lt; 0.0001). When this suppression was expressed as maximum percent inhibition, there was no difference in response during the early and late follicular and early luteal phases. However, at the midcycle surge, there was a leftward shift of the dose-response curve with significantly greater suppression of LH at the lower antagonist doses in comparison to the other cycle phases (P &lt; 0.005), but no difference at the highest dose. Thus, we draw the following conclusions. (i) There is a consistently greater degree of LH inhibition by GnRH antagonism at the midcycle surge at submaximal degrees of GnRH receptor blockade than at other phases of the menstrual cycle in normal women. (ii) This leftward shift of the dose-response relationship to GnRH receptor blockade suggests that the overall amount of GnRH secreted at the midcycle surge is less than at other cycle stages. (iii) These data confirm the importance of pituitary augmentation of the GnRH signal at the time of the midcycle gonadotropin surge in the human.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Amino Acid Sequence</subject><subject>Anatomy &amp; physiology</subject><subject>Dosage</subject><subject>Dose response relationship</subject><subject>Endocrinology</subject><subject>Female</subject><subject>Follicle Stimulating Hormone - blood</subject><subject>Follicular phase</subject><subject>Follicular Phase - blood</subject><subject>Gonadotropin-Releasing Hormone - analogs &amp; derivatives</subject><subject>Gonadotropin-Releasing Hormone - antagonists &amp; inhibitors</subject><subject>Gonadotropin-Releasing Hormone - blood</subject><subject>Hormones</subject><subject>Humans</subject><subject>LHRH receptors</subject><subject>Luteal phase</subject><subject>Luteinizing Hormone - blood</subject><subject>Menstruation</subject><subject>Molecular Sequence Data</subject><subject>Pretreatment</subject><subject>Receptors</subject><subject>Receptors, LHRH - antagonists &amp; inhibitors</subject><subject>Receptors, LHRH - metabolism</subject><subject>Reference Values</subject><subject>Secretion</subject><subject>Sex hormones</subject><subject>Women</subject><issn>0027-8424</issn><issn>1091-6490</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1994</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kc1v1DAQxS0EKtvCmQsgiwOcsrUdO04kLqiFFmn5EB_iaDnO7NYrx17spOpy4G_H0S5L4cDJ9rzfG834IfSIkjklsjzdeJ3mDZ1TMa_qht9BM0oaWlS8IXfRjBAmi5ozfh8dp7QmhDSiJkfoqCacSlrN0M9zMBF0gg5_AjddcFjii-B1F4YYNtYXu7r1K3wZYh884PMxTs_hCvDHCOF6dHoIcYvf2c5sjQO8GAew3v64bfo8xhVg6_H7XNAOfws9-Afo3lK7BA_35wn6-ub1l7PLYvHh4u3Zq0VhhBBDwZq24tqIVstOMkGbVpSSdhp0ZVpdc0mk5Lok3LSNrE1neC3KWjACreyWmpQn6OWu72Zse-gM-CFqpzbR9jpuVdBW_a14e6VW4Vpxnrtm-_O9PYbvI6RB9TYZcE57CGNSsqpYKeoJfPYPuA5j9Hk1xQgtGZGcZeh0B5kYUoqwPMxBiZpSVVOqqqGKCjWlmh1Pbo9_4PcxZv3FXp-Mv9U_DdRydG6AmyGTT_9LZuDxDlinnOmBYGUlaP7UX2_9wok</recordid><startdate>19940719</startdate><enddate>19940719</enddate><creator>Hall, Janet E.</creator><creator>Taylor, Ann E.</creator><creator>Martin, Kathryn A.</creator><creator>Rivier, Jean</creator><creator>Schoenfeld, David A.</creator><creator>Crowley, William F.</creator><general>National Academy of Sciences of the United States of America</general><general>National Acad Sciences</general><general>National Academy of Sciences</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QG</scope><scope>7QL</scope><scope>7QP</scope><scope>7QR</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TK</scope><scope>7TM</scope><scope>7TO</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>M7N</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>19940719</creationdate><title>Decreased Release of Gonadotropin-Releasing Hormone During the Preovulatory Midcycle Luteinizing Hormone Surge in Normal Women</title><author>Hall, Janet E. ; Taylor, Ann E. ; Martin, Kathryn A. ; Rivier, Jean ; Schoenfeld, David A. ; Crowley, William F.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c555t-29b64ac5ba7d72519b5371daea6cba8470774a304cb978cdc48538520eb7dfa03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1994</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Amino Acid Sequence</topic><topic>Anatomy &amp; physiology</topic><topic>Dosage</topic><topic>Dose response relationship</topic><topic>Endocrinology</topic><topic>Female</topic><topic>Follicle Stimulating Hormone - blood</topic><topic>Follicular phase</topic><topic>Follicular Phase - blood</topic><topic>Gonadotropin-Releasing Hormone - analogs &amp; derivatives</topic><topic>Gonadotropin-Releasing Hormone - antagonists &amp; inhibitors</topic><topic>Gonadotropin-Releasing Hormone - blood</topic><topic>Hormones</topic><topic>Humans</topic><topic>LHRH receptors</topic><topic>Luteal phase</topic><topic>Luteinizing Hormone - blood</topic><topic>Menstruation</topic><topic>Molecular Sequence Data</topic><topic>Pretreatment</topic><topic>Receptors</topic><topic>Receptors, LHRH - antagonists &amp; inhibitors</topic><topic>Receptors, LHRH - metabolism</topic><topic>Reference Values</topic><topic>Secretion</topic><topic>Sex hormones</topic><topic>Women</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hall, Janet E.</creatorcontrib><creatorcontrib>Taylor, Ann E.</creatorcontrib><creatorcontrib>Martin, Kathryn A.</creatorcontrib><creatorcontrib>Rivier, Jean</creatorcontrib><creatorcontrib>Schoenfeld, David A.</creatorcontrib><creatorcontrib>Crowley, William F.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Proceedings of the National Academy of Sciences - PNAS</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hall, Janet E.</au><au>Taylor, Ann E.</au><au>Martin, Kathryn A.</au><au>Rivier, Jean</au><au>Schoenfeld, David A.</au><au>Crowley, William F.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Decreased Release of Gonadotropin-Releasing Hormone During the Preovulatory Midcycle Luteinizing Hormone Surge in Normal Women</atitle><jtitle>Proceedings of the National Academy of Sciences - PNAS</jtitle><addtitle>Proc Natl Acad Sci U S A</addtitle><date>1994-07-19</date><risdate>1994</risdate><volume>91</volume><issue>15</issue><spage>6894</spage><epage>6898</epage><pages>6894-6898</pages><issn>0027-8424</issn><eissn>1091-6490</eissn><abstract>To investigate the contribution of hypothalamic gonadotropin-releasing hormone (GnRH) secretion to the midcycle gonadotropin surge in the human, the response of luteinizing hormone (LH) to competitive GnRH receptor blockade achieved by administration of a range of doses of a pure GnRH antagonist was used to provide a semiquantitative estimate of endogenous GnRH secretion. The LH response to 5, 15, 50, and 150 μ g/kg s.c. of the NAL-GLU GnRH antagonist ([Ac-D-2Nal1,D-4ClPhe2,D-Pal3,Arg5, D-4-p-methoxybenzoyl-2-aminobutyric acid6,D-Ala10]GnRH, where 2Nal is 2-naphthylalanine, 4ClPhe is 4-chlorophenylalanine, and 3Pal is 3-pyridylalanine) was measured in normal women in the early and late follicular phases of the menstrual cycle, at the time of the midcycle LH surge and in the early luteal phase. LH decreased in a dose-response fashion after administration of the GnRH antagonist in all cycle phases (P &lt; 0.0001). When this suppression was expressed as maximum percent inhibition, there was no difference in response during the early and late follicular and early luteal phases. However, at the midcycle surge, there was a leftward shift of the dose-response curve with significantly greater suppression of LH at the lower antagonist doses in comparison to the other cycle phases (P &lt; 0.005), but no difference at the highest dose. Thus, we draw the following conclusions. (i) There is a consistently greater degree of LH inhibition by GnRH antagonism at the midcycle surge at submaximal degrees of GnRH receptor blockade than at other phases of the menstrual cycle in normal women. (ii) This leftward shift of the dose-response relationship to GnRH receptor blockade suggests that the overall amount of GnRH secreted at the midcycle surge is less than at other cycle stages. (iii) These data confirm the importance of pituitary augmentation of the GnRH signal at the time of the midcycle gonadotropin surge in the human.</abstract><cop>United States</cop><pub>National Academy of Sciences of the United States of America</pub><pmid>8041716</pmid><doi>10.1073/pnas.91.15.6894</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0027-8424
ispartof Proceedings of the National Academy of Sciences - PNAS, 1994-07, Vol.91 (15), p.6894-6898
issn 0027-8424
1091-6490
language eng
recordid cdi_proquest_miscellaneous_76623584
source MEDLINE; PMC (PubMed Central); Alma/SFX Local Collection; Free Full-Text Journals in Chemistry; JSTOR
subjects Adolescent
Adult
Amino Acid Sequence
Anatomy & physiology
Dosage
Dose response relationship
Endocrinology
Female
Follicle Stimulating Hormone - blood
Follicular phase
Follicular Phase - blood
Gonadotropin-Releasing Hormone - analogs & derivatives
Gonadotropin-Releasing Hormone - antagonists & inhibitors
Gonadotropin-Releasing Hormone - blood
Hormones
Humans
LHRH receptors
Luteal phase
Luteinizing Hormone - blood
Menstruation
Molecular Sequence Data
Pretreatment
Receptors
Receptors, LHRH - antagonists & inhibitors
Receptors, LHRH - metabolism
Reference Values
Secretion
Sex hormones
Women
title Decreased Release of Gonadotropin-Releasing Hormone During the Preovulatory Midcycle Luteinizing Hormone Surge in Normal Women
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T17%3A51%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Decreased%20Release%20of%20Gonadotropin-Releasing%20Hormone%20During%20the%20Preovulatory%20Midcycle%20Luteinizing%20Hormone%20Surge%20in%20Normal%20Women&rft.jtitle=Proceedings%20of%20the%20National%20Academy%20of%20Sciences%20-%20PNAS&rft.au=Hall,%20Janet%20E.&rft.date=1994-07-19&rft.volume=91&rft.issue=15&rft.spage=6894&rft.epage=6898&rft.pages=6894-6898&rft.issn=0027-8424&rft.eissn=1091-6490&rft_id=info:doi/10.1073/pnas.91.15.6894&rft_dat=%3Cjstor_proqu%3E2365185%3C/jstor_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=201320742&rft_id=info:pmid/8041716&rft_jstor_id=2365185&rfr_iscdi=true